Details for New Drug Application (NDA): 203761
✉ Email this page to a colleague
The generic ingredient in ONDANSETRON HYDROCHLORIDE is ondansetron hydrochloride. There are twenty-eight drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the ondansetron hydrochloride profile page.
Summary for 203761
Tradename: | ONDANSETRON HYDROCHLORIDE |
Applicant: | Ipca Labs Ltd |
Ingredient: | ondansetron hydrochloride |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 4MG BASE | ||||
Approval Date: | Jan 23, 2014 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 8MG BASE | ||||
Approval Date: | Jan 23, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription